Tough competition forces innovation at Ambu

Ambu is intensifying its efforts to create the next generation of its duodenoscopes. A number of competitors are circling, and an upcoming tender is a good opportunity for income. CEO Juan Jose Gonzalez calls the new duodenoscope the biggest earner of the future.

Juan Jose Gonzalez, CEO of Ambu | Photo: Ambu/PR

As CEO of Ambu, Juan Jose Gonzalez has looked forward to announcements of tenders for single-use endoscopes in the US. However, competitors are homing in on Ambu's key business area.

The CEO expects duodendoscopes to be the biggest market within single-use endoscopes in 2024-2025, so although the company only recently launched its current product in the US, Gonzalez is already throwing his weight behind the development and launch of the next generation, while competitors circle ahead.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs